{rfName}
Ne

Documents and Files

License and Use

Licencia Icono OpenAccess

Altmetrics

Analysis of institutional authors

Martinez Puchol, AnabelAuthorDe Hollanda, AnaCorresponding AuthorTorres, FerranAuthorFlores, LiliamAuthorMartinez, AngelAuthor

Share

May 31, 2020
Publications
>
Article

New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The Time-Within-Remission Range

Publicated to: Journal of Clinical Medicine. 9 (4): E1070- - 2020-04-01 9(4), DOI: 10.3390/jcm9041070

Authors:

de Hollanda, Ana; Lecube, Albert; Angel Rubio, Miguel; Sanchez, Enric; Vilarrasa, Nuria; Gregorio Oliva, Jose; Luisa Fernandez-Soto, Maria; Salas-Salvado, Jordi; Ballesteros-Pomar, Maria D; Ciudin, Andreea; Torres, Ferran; Vidal, Concepcion; Jose Morales, Maria; Valdes, Sergio; Pellitero, Silvia; Minambres, Inka; Masmiquel, Lluis; Goday, Albert; Suarez, Lorena; Flores, Liliam; Bueno, Marta; Caixas, Assumpta; Breton, Irene; Camara, Rosa; Olbeyra, Romina; Penso, Rona; Jose de la Cruz, Maria; Simo-Servat, Andreu; Maria Pereyra-Garcia, Francisca; Teresa Lopez-Mezquita, Elena; Gils, Anna; Fidilio, Enzamaria; Bandres, Orosia; Martinez, Angel; Abuin, Jose; Marques-Pamies, Montserrat; Tuneu, Laura; Arteaga, Magdalena; Castaner, Olga; Goni, Fernando; Arrizabalaga, Cristina; Antonio Botana, Manuel; Calanas, Alfonso; Rebollo, Angel
[+]

Affiliations

Complejo Hosp Univ Vigo, Vigo 36312, Spain - Author
Hosp Basurto, Bilbao 48013, Spain - Author
Hosp Cent Defensa Gomez Ulla, Madrid 28047, Spain - Author
Hosp Clin Barcelona, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Clin Pharmacol Deparment, Med Stat Core Facil, Barcelona 08036, Spain - Author
Hosp Clin San Carlos IDISSC, Madrid 28040, Spain - Author
Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IISGM, Madrid 28007, Spain - Author
Hosp Leon, Leon 24008, Spain - Author
Hosp Mutua Terrassa, Terrassa 08221, Spain - Author
Hosp Royo Villanova, Zaragoza 50015, Spain - Author
Hosp Univ & Politecn Fe, Valencia 46026, Spain - Author
Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain - Author
Hosp Univ Cent Asturias, Oviedo 33011, Spain - Author
Hosp Univ Fdn Jimenez Diaz, Madrid 28040, Spain - Author
Hosp Univ Germans Trias Pujol, Inst Invest Germans Trias & IGTP, Badalona 08916, Spain - Author
Hosp Univ Lucus Augusti, Lugo 27003, Spain - Author
Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife 38010, Spain - Author
Hosp Univ Reina Sofia, Cordoba 14004, Spain - Author
Hosp Univ San Cecilio, Granada 18016, Spain - Author
Hosp Univ Son Llatzer, Inst Invest Sanitaria Ias Islas Baleares IdISBa, Palma de Mallorca 07198, Spain - Author
Hosp Univ Vall DHebron, Barcelona 08035, Spain - Author
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain - Author
Inst Salud Carlos III ISCIII, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid 28029, Spain - Author
Inst Salud Carlos III ISCIII, CIBER Obesidad & Nutr CIBEROBN, Madrid 28029, Spain - Author
Univ Autonoma Barcelona, Biostat Unit, Fac Med, Barcelona 08193, Spain - Author
Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Barcelona 08041, Spain - Author
Univ Autonoma Barcelona, Inst Hosp Mar Invest Mediques IMIM, Parc Salut Mar, Barcelona 08003, Spain - Author
Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, Hosp Univ Parc Tauli, Sabadell 08208, Spain - Author
Univ Lleida, Inst Recerca Biomed Lleida IRBLleida, Hosp Univ Arnau Vilanova, Grp Recerca Obesitat, Lleida 25198, Spain - Author
Univ Malaga, Inst Invest Biomed Malaga IBIMA, Hosp Reg Univ Malaga, Malaga 29010, Spain - Author
Univ Rovita & Virgili Reus, Inst Invest Sanitaria Pere Virgili IISPV, Hosp Univ St Joan Reus, Tarragona 43204, Spain - Author
See more

Abstract

Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the time-within-remission range as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 +/- 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, time-within-remission range and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 +/- 9.2 years old, body mass index (BMI) 46.3 +/- 6.9 kg/m(2)) underwent primary bariatric procedures. Time-within-remission range were 83.3% (33.3-91.6) after gastric bypass, 68.7% (7.1-87.5) after sleeve gastrectomy and 90% (83.3-92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the time-within-remission range. The association of bariatric techniques with time-within-remission range, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34-5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40-0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The time-within-remission range unveils a superiority of gastric bypass compared to sleeve gastrectomy.
[+]

Keywords

bariatric surgeryfollow-uplaparoscopic sleeve gastrectomymetabolic controlmetabolic surgeryobesitypropensity score methodstime-within-remission rangetype 2 diabetesweight-lossBariatric surgeryCirurgia de l'obesitatDiabetesDiabetisFollow-upLaparoscopic sleeve gastrectomyMetabolic controlMetabolic surgeryObesityObesity surgeryPropensity score methodsTime-within-remission rangeType 2 diabetesWeight-lossY-gastric bypass

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Journal of Clinical Medicine due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2020, it was in position 39/167, thus managing to position itself as a Q1 (Primer Cuartil), in the category Medicine, General & Internal.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2026-04-05:

  • WoS: 7
  • Scopus: 6
  • Europe PMC: 3
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-05:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 86.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 86 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 13.
  • The number of mentions on the social network X (formerly Twitter): 23 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
  • Assignment of a Handle/URN as an identifier within the deposit in the Institutional Repository: http://hdl.handle.net/2445/173083
[+]

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (De Hollanda Ramírez, Ana María) .

the author responsible for correspondence tasks has been De Hollanda Ramírez, Ana María.

[+]

Awards linked to the item

This study was supported by the Spanish Society of Endocrinology and Nutrition (SEEN). The RICIBA and RICIBA-DM are property of the Spanish Society of Endocrinology and Nutrition (SEEN). J.S.S. gratefully acknowledges the financial support by ICREA under the ICREA Academia programme.
[+]

Related Items